Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Minority Interest (2016 - 2025)

U S Physical Therapy's Minority Interest history spans 12 years, with the latest figure at $174.7 million for Q3 2023.

  • For Q3 2023, Minority Interest rose 17.92% year-over-year to $174.7 million; the TTM value through Sep 2023 reached $174.7 million, up 17.92%, while the annual FY2022 figure was $167.5 million, 7.89% up from the prior year.
  • Minority Interest for Q3 2023 was $174.7 million at U S Physical Therapy, up from $165.5 million in the prior quarter.
  • Across five years, Minority Interest topped out at $174.7 million in Q3 2023 and bottomed at $132.3 million in Q4 2020.
  • The 5-year median for Minority Interest is $140.5 million (2020), against an average of $147.5 million.
  • The largest annual shift saw Minority Interest rose 26.93% in 2019 before it dropped 3.93% in 2020.
  • A 5-year view of Minority Interest shows it stood at $137.8 million in 2019, then fell by 3.93% to $132.3 million in 2020, then grew by 17.32% to $155.3 million in 2021, then grew by 7.89% to $167.5 million in 2022, then grew by 4.29% to $174.7 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Minority Interest are $174.7 million (Q3 2023), $165.5 million (Q2 2023), and $164.3 million (Q1 2023).